Peptide having angiotensin converting enzyme inhibitory effect

Details Peptide having angiotensin converting enzyme inhibitory effect Peptide having angiotensin converting enzyme inhibitory effect

2006-04-04

2006-04-04

Campell, Bruce R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07022676

ABSTRACT:
A peptide Met-Lys-Pro, which is obtained by chemical synthesis ot hydrolysis of casein, is used as the active ingredient of angiotensin converting enzyme inhibitors or hypotensive drugs.

REFERENCES:
patent: 7-313185 (1995-12-01), None
patent: 11-343297 (1999-12-01), None
Maeno et al, Identification of an Antihypertensive Peptide from Casein Hydrolysate Produced by a Proteinase fromLactobacillus helveticusCP790, Journal of Dairy Science (1996), vol. 79, 1316-1321.

Affiliated with

Also associated with

Rating

Peptide having angiotensin converting enzyme inhibitory effect does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide having angiotensin converting enzyme inhibitory effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide having angiotensin converting enzyme inhibitory effect will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3528146